Physician profile

Thomas James Beadle

Vascular Surgery · Fayetteville, NC

NPI 1164606026

$4,946.06

in general payments reported to CMS, 2019-2025

30 companies · $437 in 2025

The $437 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,890.79

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Silk Road Medical, INC. $1,161.13 2019-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Inari Medical, INC. $818.99 2020-2025 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Medtronic Vascular, INC. $381.22 2019-2020
Medtronic, INC. $305.73 2022-2025 Hawkone, Concertotm, Mvp
Getinge USA Sales, LLC $260.84 2020
Janssen Pharmaceuticals, INC $227.08 2019-2024 Xarelto
Philips North America LLC $200.76 2022
Boston Scientific Corporation $153.83 2021-2025 Jetstream Sc, Varithena Administration Pack, Ekosonic
Bolton Medical INC $152.60 2019-2023 Relay Thoracic Stent-Graft With Plus Delivery System
Cardiovascular Systems INC. $145.58 2019-2020
Smith+Nephew, INC. $128.10 2023-2025 Renasys Go V2 Home, Grafix Pl, Renasys Touch
Cook Medical LLC $127.79 2019-2025 Zilver Ptx, Zenith Spiral-Z
Davol INC. $120.36 2020-2021
Penumbra, INC. $118.28 2022
Abiomed $95.41 2022-2025
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Surmodics, INC. $66.12 2025 Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter
Kerecis Limited $57.77 2019-2024 Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose
Tactile Systems Technology INC $56.57 2019-2025 Nimbl, Flexitouch Plus
Bard Peripheral Vascular, INC. $51.30 2023-2024 Rotarexs 6 F X 135 Cm
Stryker Corporation $45.43 2025 Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit
Cvrx, INC. $40.24 2023-2024 Barostim Neo System
Ethicon US, LLC $38.77 2023 Echelon Flex
Abbott Laboratories $35.66 2024-2025 Perclose Prostyle, Esprit
Cashflow Solutions, LLC $32.66 2022-2024 Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt
Terumo Medical Corporation $32.24 2023-2024 Angio-Seal, Glidewire, Metacross Otw
Teleflex LLC $24.56 2024 Manta
Merit Medical Systems INC $20.58 2024 Embosphere Microspheres, Swiftninja Sterble Cor Micro
Cardiva Medical, INC. $17.55 2025 Cardiva Vascade 6/7f Vcs
W. L. Gore & Associates, INC. $15.97 2024 Gore Viabahn Endoprosthesis With Heparin
Aroa Biosurgery Incorporated $12.94 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas James Beadle

$4,946.06

in general payments reported 2019-2025

Years
2019-2025
Top company
Silk Road Medical, INC.
Context
The $437 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/396307/thomas-james-beadle

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.